The Company & The University Of Western Australia Knows There Is Massive Value In The Patentable MDMA-like Compounds, Hence They Have Patents At A National Filing Stage Worldwide…..A Massive Tick From Me, Many Deals Could & Will Be Struck Here $$$$
Great To See The Fully-funded Preclinical Screening Program For Pain ( PSPP ) For RX7 Is Currently Completing Tier 2 evaluations ( assessment of neurotoxicity and efficacy in acute to chronic pain models ) & Expected To Advance To Tier 3 ( disease-specific models ) in H2,2024. I Still Think This Could Be The Catalyst To A Multi Bagger Here…$$$$
Business As Usual With The Growth Plans For Advanced Treatment and Clinical Service Expansion, Although Currently Cash Burn But Company Making For Growth, With Future Buy Out…Take Over Potential.
A Win Win On All Fronts, As Far As I’m Concerned And Great To Get A Company Update…Which Has Been A Bit Lapse Of Late.
This Is Still Priced At Peanuts For The Monkey’s….What A Bargain!
Cheers
- Forums
- ASX - By Stock
- EMD
- Ann: June 2024 Quarterly Activities Report and Appendix 4C
Ann: June 2024 Quarterly Activities Report and Appendix 4C, page-3
Featured News
Add EMD (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
-0.003(5.68%) |
Mkt cap ! $16.97M |
Open | High | Low | Value | Volume |
4.3¢ | 4.3¢ | 4.1¢ | $19.81K | 472.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 90909 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 199981 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 90909 | 0.041 |
7 | 162260 | 0.040 |
1 | 60000 | 0.033 |
1 | 16000 | 0.032 |
1 | 17000 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 199981 | 1 |
0.044 | 183788 | 1 |
0.046 | 135180 | 1 |
0.047 | 44998 | 2 |
0.048 | 100000 | 1 |
Last trade - 14.48pm 30/07/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online